# Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

Study · id `cardio:ct-nct01369069` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01369069](<https://clinicaltrials.gov/study/NCT01369069>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01369069

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1151 participants.

## Technical summary

Registry record NCT01369069. Randomized; double masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2018-11-19 (actual). Results posted on 2019-12-16.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1151 participants (enrolled count; ClinicalTrials.gov record NCT01369069, source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)
- Started: 2012-04 (actual) (ClinicalTrials.gov record NCT01369069, source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)
- Primary completion: 2018-11-19 (actual) (ClinicalTrials.gov record NCT01369069, source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)
- Completion: 2018-11-19 (actual) (ClinicalTrials.gov record NCT01369069, source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)
- Results first posted: 2019-12-16 (ClinicalTrials.gov record NCT01369069, source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01369069, source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01369069-2019-12-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial
- Acronym: SHINE
- Condition: Acute Ischemic Stroke
- Condition: Diabetes
- Condition: Hyperglycemia
- Intervention (Drug): IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Intervention (Drug): Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
- Lead sponsor: University of Virginia
- Lead sponsor class: OTHER
- Collaborator: Neurological Emergencies Treatment Trials Network (NETT)
- Collaborator class: NETWORK
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Virginia (`cardio:org-university-of-virginia`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial (`cardio:pubmed-31334795`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Glucose Control and Risk of Symptomatic Intracerebral Hemorrhage Following Thrombolysis for Acute Ischemic Stroke: A SHINE Trial Analysis (`cardio:pubmed-38626363`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 97d025a8862c63b310720f0eb8fdb2443336d2b3e3ccd8f6b2c0381c3fec96cd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
